Northwood, United Kingdom

Robin K S Phillps

This inventor holds 1 USPTO granted patent. Top assignee: S.l.a. Pharma Ag. Active years: 2014.


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Robin K S Phillips

Introduction

Robin K S Phillips is a notable inventor based in Northwood, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of anorectal disorders. His innovative approach combines the use of cholinergic agents and calcium channel blockers to provide effective pain management.

Latest Patents

Phillips holds a patent for a topical pharmaceutical composition that comprises a cholinergic agent or a calcium channel blocker. This patent outlines a method and composition for treating anorectal disorders and controlling associated pain. The method involves administering therapeutically effective amounts of a calcium channel blocker, either alone or in combination with a nitric oxide donor. Suitable calcium channel blockers mentioned in the patent include amlodipine, diltiazem, and verapamil, among others.

Career Highlights

Phillips is associated with S.L.A. Pharma AG, where he continues to work on innovative pharmaceutical solutions. His expertise in the field has led to advancements that benefit patients suffering from specific medical conditions. His dedication to research and development has positioned him as a key figure in pharmaceutical innovation.

Collaborations

Phillips collaborates with Michael A Kamm, contributing to the development of new therapeutic methods and compositions. Their partnership exemplifies the importance of teamwork in advancing medical science.

Conclusion

Robin K S Phillips is a distinguished inventor whose work in pharmaceutical compositions has the potential to improve the quality of life for many individuals. His innovative methods and dedication to research highlight the importance of continued advancements in medical treatments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…